The Traderszone Network

Published in TZ Latest News 22 September, 2017 by The TZ Newswire Staff

Why Exelixis, Inc. Slumped Today

Exelixis (NASDAQ: EXEL) is down 12.3% at 2:18 p.m. EDT after an analyst at Leerink Partners downgraded the biotech to market perform. Management also sold some shares, which could be contributing to the downward direction of the share price.

read more